Tocilizumab Biosimilar, MSB11456, Demonstrates Similar Pharmacokinetics, Safety Profiles HCP Live, 24 Feb 2023 Pharmacokinetic similarity, including immunogenicity and safety profiles, was observed in the tocilizumab biosimilar, MSB11456…